Cargando…
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma
BACKGROUND: Insulin like growth factor binding protein 7 (IGFBP7) is a secreted protein binding insulin like growth factor 1 (IGF-1), insulin, vascular endothelial growth factor A (VEGFA), and activin A. It antagonizes bone morphogenetic proteins and is involved in the tumour propagation of solid as...
Autores principales: | Bolomsky, Arnold, Hose, Dirk, Schreder, Martin, Seckinger, Anja, Lipp, Susanne, Klein, Bernard, Heintel, Daniel, Ludwig, Heinz, Zojer, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333268/ https://www.ncbi.nlm.nih.gov/pubmed/25887188 http://dx.doi.org/10.1186/s13045-014-0105-1 |
Ejemplares similares
-
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
por: Schneller, Anja, et al.
Publicado: (2021) -
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
por: Bolomsky, Arnold, et al.
Publicado: (2016) -
Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma
por: Cowan, Graeme, et al.
Publicado: (2015) -
SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of ‘biomarker-defined early multiple myeloma’—a systematic review with meta-analysis
por: Ludwig, Heinz, et al.
Publicado: (2023) -
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
por: Bolomsky, Arnold, et al.
Publicado: (2018)